Literature DB >> 7189746

Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.

C R Young, M M Levine, J P Craig, R Robins-Browne.   

Abstract

A microtiter enzyme-linked immunosorbent assay (ELISA) to measure immunoglobulin G cholera antitoxin in human serum has been developed. The ELISA employs commercially available reagents, including cholera enterotoxin and goat anti-human immunoglobulin G. It is specific, sensitive, and reproducible and requires as little as 5 microliter of serum. ELISA, moreover, permits quantitative determination of cholera antitoxin at a single serum dilution of 1:200. A total of 162 pre- and post-challenge sera from 49 volunteers who ingested Vibrio cholerae classical biotype, and 165 sera from 43 volunteers who ingested V. cholerae El Tor biotype, were tested for cholera antitoxin by ELISA and by the rabbit skin vascular permeability factor assay. The correlation between the two assays was statistically significant (P less than 0.001). ELISA for immunoglobulin G cholera antitoxin thus provides a valuable in vitro correlate of in vivo toxin-neutralizing capacity. Microtiter ELISA permits duplicate evaluation of at least 14 sera per 96-well plate including blanks and controls, is readily adapted to use in field studies, and therefore is particularly well suited to seroepidemiological surveys.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189746      PMCID: PMC550792          DOI: 10.1128/iai.27.2.492-496.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Authors:  M M Levine; T P Hughes; C R Young; S O'Donnell; J P Craig; H P Holley; E J Bergquist
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Practical colorimeter for direct measurement of microplates in enzyme immunoassay systems.

Authors:  T R Clem; R H Yolken
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Neutralization of cholera enterotoxin-induced steroidogenesis by specific antibody.

Authors:  S T Donta
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

4.  Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.

Authors:  R A Cash; S I Music; J P Libonati; M J Snyder; R P Wenzel; R B Hornick
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

5.  Cutaneous responses to cholera skin toxin in man. I. Responses in unimmunized American males.

Authors:  J P Craig; E R Eichner; R B Hornick
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

6.  Antitoxic immunity in experimental canine cholera.

Authors:  G T Curlin; J P Craig; A Subong; C C Carpenter
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

7.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

8.  Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

9.  Radioimmunoassay for the antigenic determinants of cholera toxin and its components.

Authors:  K E Hejtmancik; J W Peterson; D E Markel; A Kurosky
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

10.  Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.

Authors:  A S Benenson; A Saad; W H Mosley; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  13 in total

1.  Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

Authors:  S Migasena; P Pitisuttitham; P Suntharasamai; B Prayurahong; W Supanaranond; V Desakorn; R E Black
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

2.  Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

Authors:  S Migasena; V Desakorn; P Suntharasamai; P Pitisuttitham; B Prayurahong; W Supanaranond; R E Black
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.

Authors:  M M Levine; P Ristaino; G Marley; C Smyth; S Knutton; E Boedeker; R Black; C Young; M L Clements; C Cheney
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 4.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

5.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.

Authors:  R P Viscidi; R H Yolken; B E Laughon; J G Bartlett
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

7.  Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.

Authors:  S D Sears; K Richardson; C Young; C D Parker; M M Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  Seroepidemiology of cholera in Gulf coastal Texas.

Authors:  M D Hunt; W E Woodward; B H Keswick; H L Dupont
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.